Proceedings of the National Academy of Sciences, Volume 122, Issue 22, June 2025.
SignificanceBispecific T cell engagers (TcEs) are immunotherapeutic drugs that trigger the destruction of cancer cells by linking T cells to cancer cells through specific surface molecules (antigens). We designed a series of TcEs with varying distances …
Read More